"
Team:Wageningen UR
From 2012.igem.org
TSlijkhuis (Talk | contribs) |
TSlijkhuis (Talk | contribs) |
||
| Line 27: | Line 27: | ||
</div> | </div> | ||
| + | <div class="homeLB"> | ||
| + | <div class="col"> | ||
| + | <h2 class="ulc1">The Team</h2> | ||
| + | <p><a href="https://2012.igem.org/Team:Wageningen_UR/Team" title="Meet the Team" class="bigbutton bTeam">Meet the team!</a></p> | ||
| + | </div> | ||
| + | </div> | ||
| + | |||
</div> | </div> | ||
| Line 42: | Line 49: | ||
<h2 class="ulc3">The Constructor</h2> | <h2 class="ulc3">The Constructor</h2> | ||
<p><a href="https://2012.igem.org/Team:Wageningen_UR/TheConstructor" title="The Constructor" class="bigbutton bConstructor">An application that assists you in creating your cloning strategies for your iGEM project.</a></p> | <p><a href="https://2012.igem.org/Team:Wageningen_UR/TheConstructor" title="The Constructor" class="bigbutton bConstructor">An application that assists you in creating your cloning strategies for your iGEM project.</a></p> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
</div> | </div> | ||
Revision as of 15:23, 25 October 2012
Project Overview
A standardized tool for site specific drug delivery using Virus-Like Particles
Medicines are generally active in a non-site-specific fashion, affecting the whole patient, including healthy tissue. Therefore, we attempt to specifically target diseased areas by packaging medicines inside Virus-Like Particles (VLPs). VLPs are not infectious, as they are built solely from viral coat proteins. We designed a modular Plug and Apply system that enables modifications to these coat proteins. The system facilitates the linkage of numerous ligands to the coat protein, thereby creating site-specific carriers. After expression of coat protein genes in Escherichia coli the VLPs were assembled in vitro, yielding modified Virus-Like Particles. Medicines can be packed using the Plug and Apply system or simply by addition during VLP assembly. Concluding, VLPs can be used as universal carriers for site-specific drug delivery, allowing customization to a variety of diseases while decreasing side effects for patients during treatment.
The Team
Europe Jamboree
Gold Medal
Best Presentation
The Constructor
An application that assists you in creating your cloning strategies for your iGEM project.
Human Practices
We ..... ..... ... ... .. .. .. .. .................. .........
